• FDA Approves Wegovy (semaglutide) to Treat Adults with Obesity drugs
    June 07, 2021
    Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the new drug application (NDA) for Wegovy™ (semaglutide) injection 2.4 mg, the first-and-only prescription weight-loss medication with once-weekly dosing.
PharmaSources Customer Service